免疫球蛋白A脏病:新的治疗选择
Arun Rajasekaran1,2, Dana V Rizk2, Kirk N Campbell3
1Renal Medicine Associates, Albuquerque, New Mexico, USA.
Annual review of medicine
|January 27, 2026
概括
免疫球蛋白A脏病 (IgAN) 是导致功能衰竭的主要病. 最近的进展为减少脏损失和阻止疾病进展提供了新的多向治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是全球最常见的原发性淋巴细胞疾病.
- 它的特点是免疫复合物的沉积,导致球膜损伤和脏损失.
- 大多数Igan患者随着时间的推移而进展到功能衰竭.
研究的目的:
- 审查IGAN的最新治疗进展.
- 为了突出了解IGAN病变的进展.
- 讨论管理IGAN的多目标方法.
主要方法:
- 对最近评估和批准用于Igan治疗的药理学药物的审查.
- 分析了解IGAN病变的进展.
- 讨论针对免疫学和慢性病机制的治疗策略.
主要成果:
- 在了解IgAN病原发生方面取得了重大进展.
- 最近,许多药理学药物被评估和批准.
- 替代结果,如减少蛋白尿症,被接受用于加速药物批准.
结论:
- 多目标方法为IGAN患者提供最大的益处.
- 新的治疗发展重点是减少脏损失和阻止疾病的进展.
- 该领域已经看到大量新的药理学药物用于Igan治疗.
相关概念视频
Immunoglobulin-like Cell Adhesion Molecules
4.4K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.4K
Open Angle Glaucoma: Treatment
990
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
990
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Parkinson's Disease: Treatment
1.1K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Alzheimer's Disease: Treatment
914
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
914
Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K


